Safety and early efficacy analysis of a novel combination of the PARP inhibitor veliparib (ABT-888) plus bendamustine and rituximab in patients with lymphoma Meeting Abstract


Authors: Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Moskowitz, C. H.; Noy, A.; Portlock, C. S.; Palomba, M. L.; Straus, D. J.; Younes, A.; Zelenetz, A. D.; Chen, A.; Little, R. F.; Fallon, F.; Whang, J. H.
Abstract Title: Safety and early efficacy analysis of a novel combination of the PARP inhibitor veliparib (ABT-888) plus bendamustine and rituximab in patients with lymphoma
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349242704065
PROVIDER: wos
Notes: Meeting Abstract: 1739 -- Source: Wos
MSK Authors
  1. Carol Portlock
    181 Portlock
  2. Craig Moskowitz
    375 Moskowitz
  3. Ariela Noy
    208 Noy
  4. Maria Lia Palomba
    128 Palomba
  5. Steven M Horwitz
    364 Horwitz
  6. Andrew D Zelenetz
    556 Zelenetz
  7. Alison Moskowitz
    148 Moskowitz
  8. Paul Hamlin
    174 Hamlin
  9. Matthew J Matasar
    122 Matasar
  10. David J Straus
    213 Straus
  11. Juho Patrick Whang
    3 Whang